IFNγ/TNFα synergism in MHC class II induction: Effect of nicotinamide on MHC class II expression but not on islet-cell apoptosis

Diabetologia

Volumn 45, Issue 3, 2002, Pages 385-393

  Kim, K A ^a   Kim, S ^b   Chang, I ^b   Kim, G S ^c   Min, Y K ^a   Lee, M K ^a   Kim, K W ^a   Lee, M S ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Samsung Medical Center   (South Korea)

^c University of Ulsan College of Medicine   (South Korea)

Author keywords

CIITA; INF ; IRF 1; MHC; Nicotinamide; STAT1; TNF ; Type I diabetes mellitus

Indexed keywords

CYTOKINE; GAMMA INTERFERON; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NICOTINAMIDE; TUMOR NECROSIS FACTOR ALPHA;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CONTROLLED STUDY; FEMALE; FLOW CYTOMETRY; IMMUNOBLOTTING; IMMUNOCYTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE TRANSFER; MOUSE; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RIBONUCLEASE PROTECTION ASSAY;

ANIMALS; APOPTOSIS; CELL LINE, TRANSFORMED; DRUG SYNERGISM; GENE EXPRESSION REGULATION; GENES, MHC CLASS II; HISTOCOMPATIBILITY ANTIGENS CLASS II; INSULINOMA; INTERFERON TYPE II; MICE; MICE, INBRED NOD; NIACINAMIDE; PANCREATIC NEOPLASMS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036211558     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-001-0755-8     Document Type: Article

References (53)

1. Apoptosis of pancreatic beta-cells detected in accelerated diabetes of NOD mice: No role of Fas-Fas ligand interaction in autoimmune diabetes
2. Inhibition of autoimmune diabetes by Fas ligand: The paradox is solved
3. IFN-gamma/TNF-alpha synergism as the final effector in autoimmune diabetes: A key role for STAT1/IFN regulatory factor-1 pathway in pancreatic beta cell death
4. HLA class II induction in human islet cells by interferon-gamma plus tumour necrosis factor or lymphotoxin
5. Inhibition of cytokine-induced MHC class II but not class I molecule expression on mouse islet cells by niacinamide and 3-aminobenzamide
6. Expression of major histocompatibility antigens on pancreatic islet cells
7. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity
8. Interferon-gamma induces the expression of HLA-A B, C but not HLA-DR on human pancreatic beta-cells
9. Macrophages T cell receptor usage, and endothelial cell activation in the pancreas at the onset of insulin-dependent diabetes mellitus
10. Pancreas in recent onset insulin-dependent diabetes mellitus. Changes in HLA, adhesion molecules and autoantigens, restricted T cell receptor V beta usage, and cytokine profile
11. In situ characterization of autoimmune phenomena and expression of HLA molecules in the pancreas in diabetic insulitis
12. Aberrant expression of HLA-DR antigens by insulin-containing beta-cells in recent-onset type I diabetes mellitus
13. Class-II and IL2 receptor positive cells in the pancreas of NOD mice
14. Interferon-gamma induces HLA-DR expression by thyroid epithelium
15. Transgenic mice with I-A on islet cells are normoglycemic but immunologically intolerant
16. Diabetes and tolerance in transgenic mice expressing class II MHC molecules in pancreatic beta cells
17. Antigen presenting function of class II MHC expressing pancreatic beta cells
18. Pancreatic expression of B7 co-stimulatory molecules in the non-obese diabetic mouse
19. Expression of the co-stimulator molecule B7-1 in pancreatic beta-cells accelerates diabetes in the NOD mouse
20. The role of CD4+ and CD8+ T cells in the destruction of islet grafts by spontaneously diabetic mice
21. Effects of inhibitors of ADP-ribosylation on macrophage activation
22. Nicotinamide inhibits IRF-1 mRNA induction and prevents IL-1 beta-induced nitric oxide synthase expression in pancreatic beta cells
23. Interferon-gamma-induced interferon regulatory factor-1 (IRF-1) expression in rodent and human islet cells precedes nitric oxide production
24. Preventive and therapeutic effects of large-dose nicotinamide injections on diabetes associated with insulitis. An observation in nonobese diabetic (NOD) mice
25. Effect of nicotinamide therapy upon B-cell function in newly diagnosed Type I (insulin-dependent) diabetic patients
26. Prevention or delay of Type I (insulin-dependent) diabetes mellitus in children using nicotinamide
27. The use of nicotinamide in the prevention of type 1 diabetes
28. Expression of intercellular adhesion molecule 1 on pancreatic beta-cells accelerates beta-cell destruction by cytotoxic T-cells in murine autoimmune diabetes
29. The first external domain of the nonobese diabetic mouse class II I-A beta chain is unique
30. Expression of MHC class II molecules in different cellular and functional compartments is controlled by differential usage of multiple promoters of the transactivator CIITA
31. Expression of class II major histocompatibility complex antigens on pancreatic B cells in the NOD mouse
32. The natural history of lymphocyte subsets infiltrating the pancreas of NOD mice
33. Differential expression and regulation of MHC products in the endocrine and exocrine cells of the human pancreas
34. Tumour necrosis factors alpha and beta inhibit virus replication and synergize with interferons
35. IFN-gamma and tumor necrosis factor-alpha. Cytotoxicity to murine islets of Langerhans
36. Cytotoxic effect of IFN-gamma plus TNF-alpha on human islet cells
37. Adoptive transfer of diabetes into immunodeficient NOD-scid/scid mice. Relative contributions of CD4+ and CD8+ T-cells from diabetic versus prediabetic NOD.NON-Thy-1 a donors
38. Autologous CD4 T-cell responses to ectopic class II major histocompatibility complex antigen-expressing single-cell islet cells: An in vitro insight into the pathogenesis of lymphocytic insulitis in non-obese diabetic mice
39. Reduced incidence and delayed onset of diabetes in perforin-deficient nonobese diabetic mice
40. In vivo expression of perforin by CD8+ lymphocytes in autoimmune disease. Studies on spontaneous and adoptively transferred diabetes in non-obese diabetic mice
41. Lymphocyte-mediated cytotoxicity: Two pathways and multiple effector molecules
42. Mechanisms of beta cell death in diabetes: A minor role for CD95
43. Regulation of MHC gene expression
44. Regulation of MHC class II gene expression
45. Complementation cloning of an MHC class II transactivator mutated in hereditary MHC class II deficiency (or bare lymphocyte syndrome)
46. Regulation of MHC class II genes: Lessons from a disease
47. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression
48. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA
49. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes
50. Activation of the MHC class II transactivator CIITA by interferon-gamma requires cooperative interaction between Stat1 and USF-1
51. Protective effect of nicotinamide and 3-aminobenzamide on islet cell damage induced by gamma-interferon and tumor necrosis factor
52. Effect of nicotinamide treatment on the residual insulin secretion in Type I (insulin-dependent) diabetic patients
53. Nicotinamide decreases MHC class II but not MHC class I expression and increases intercellular adhesion molecule-1 structures in non-obese diabetic mouse pancreas